Protoporphyrin IX ͑PpIX͒-encapsulated mesoporous silica nanoparticles were synthesized, characterized, and utilized for photodynamic therapy ͑PDT͒ of cancer. Silica encapsulation is relatively transparent for activated light and can protect the PpIX against denaturation induced by the extreme bioenvironment. The mesoporous silica can also ensure that the encapsulated PpIX can be wellcontacted with oxygen, stimulated, and released. PpIX-encapsulated colloidal mesoporous silica nanoparticles were uptaken by tumor cells in vitro, and the effect of photon-induced toxicity was demonstrated after comparison with some control experiments. The surface of PpIX-encapsulated silica nanoparticles can be grafted with appropriate functionalized groups and conjugated with certain biomolecules for specific targeting.
Introduction
Photodynamic therapy ͑PDT͒ is a light-activated treatment for malignant or premalignant cancer tumors and other diseases. It has emerged as an important research area in biophotonics. [1] [2] [3] [4] PDT is based on the fact that some photosensitizers ͑PSs͒ can be accumulated to a higher concentration in tumor cells than in healthy cells upon systemic administration. By matching the wavelength of the therapeutic light to the absorption peak of the sensitizers, most of the light is absorbed by the PSs, and the excited PS molecules can then transfer their energy to surrounding oxygen molecules, which are normally in their triplet ground state. This results in the formation of reactive oxygen species ͑ROSs͒ such as singlet oxygen ͑ 1 O 2 ͒ or free radicals. ROSs are responsible for oxidizing various cellular compartments, resulting in irreversible damage to tumor cells. [2] [3] [4] PSs, oxygen, and light are three crucial components for this photon-induced toxicity effect. 5, 6 Most existing PSs are hydrophobic and may aggregate easily in a biological environment. 7, 8 Even for hydrophilic PSs, the selective accumulation in tumor tissues is not high enough for clinical use. To overcome these limitations, colloidal carriers for PSs, such as liposomes and polymeric micelles, have been investigated. 9, 10 For the study described in this paper, colloidal mesoporous silica nanoparticles with encapsulated protoporphyrin IX ͑PpIX͒, which has been widely investigated and officially approved for use in clinical treatments, 11, 12 were synthesized and utilized as drug carriers.
This nanoformulation has many advantages over PSencapsulated polymer/liposomes. The PS-encapsulated silica nanoparticles can be easily prepared with a desired size, shape, and porosity, and are very stable. 13 They are more biocompatible than other nanomaterials, and they can effectively protect the doped PSs against denaturation induced by the extreme bioenvironment. 14 Silica encapsulation is relatively transparent for both the activated light and signal light. The mesoporosity property can also ensure oxygen contact with encapsulated PSs so that they can be effectively stimulated and released. The ultrasmall size ͑Ͻ50 nm͒ and surface charge of silica nanoparticles can help them be uptaken by tumor cells through the "enhanced permeability and retention effect," 15, 16 To accumulate PSs selectively in tumor tissues and reduce the dosage of PSs, their surfaces can be functionalized with various groups and further conjugated with antibodies for specific uptake in an in vivo experiment. 17 In this paper, we report an investigation that used mesoporous silica nanoparticles with encapsulated PpIX for PDT treatment. The nanoparticles were synthesized, characterized, and utilized for in vitro imaging of tumor cells. The effect of photon-induced toxicity of this nanoformulation was also demonstrated after comparison with some control experiments. The PpIX-encapsulated mesoporous silica nanoparticles showed good potential applications to, e.g., photodynamic therapy for cancers.
Experiments

Chemicals
Aerosol-OT ͑98%͒, Vinyltriethoxysilane ͑VTES͒ ͑97%͒, ͑3-Aminopropyl͒triethoxysilane ͑APTES͒ ͑98%͒, PpIX, and 1,3diphenylisobenzofuran ͑DPBF͒ were purchased from Sigma Aldrich. Dimethylsulfoxide ͑DMSO͒ and 1-butanol ͑99.8%͒ were purchased from Sinopharm Chemical Reagent Co., Ltd. ͑China͒. Cell-culture products, unless otherwise mentioned, were purchased from GIBCO. All the above chemicals were used without any additional purification, and distilled ͑DI͒ water was used in all the experimental steps.
Synthesis of PpIX-Encapsulated Silica Nanoparticles
PpIX-encapsulated silica nanoparticles were synthesized in the nonpolar core of aerosol-OT/DMSO/ water micelles ͑as shown in Fig. 1͒ . 13 Typically, the micelles were prepared by dissolving a certain amount of aerosol-OT and 1-butanol in 10 ml of DI water by vigorous magnetic stirring. PpIX in DMSO ͑10 mM͒ was then added to the solution under magnetic stirring. Half an hour later, a certain amount of neat VTES was added to the micellar system, and the resulting solution was stirred for about 1 hour. Next, silica nanoparticles were precipitated by adding APTES and stirred for 20 hours at room temperature. After the formation of the nanoparticles, surfactant aerosol-OT, cosurfactant 1-butanol, residual VTES, and APTES, and an extremely tiny amount of soluble PpIX molecules were removed by dialysis. The dialyzed solution was then filtered through a hydrophilic membrane filter with 0.45-m cutoff to separate the PpIXencapsulated silica nanoparticles from the PpIX. The PpIX molecules were barely soluble in DI water and their insoluble aggregates were blocked by the membrane, while the small hydrophilic silica nanoparticles could pass through the membrane very easily. The sample was kept for later use after purification. The same protocol was used to synthesize Nile red-encapsulated silica nanoparticles, which were used in some control experiments.
Experimental Characterization
Transmission electron microscope ͑TEM͒ analyses were made with JEOL's JEM-1200EX equipment. The as-synthesized PpIX-encapsulated silica nanoparticles were used for investi-gation. The ultraviolet ͑UV͒ and visible ͑vis͒ extinction spectra were recorded from 250 to 900 nm with a Shimadzu 2550 UV-vis scanning spectrophotometer at room temperature. The photoluminescence spectra were obtained by a fluorescence spectrophotometer ͑F-2500, HITACHI, Japan͒ with a xenon lamp excitation ranging from 180 to 800 nm.
Detection of Reactive Oxygen Species ͑ROSs͒
Chemical oxidation of DPBF in the aqueous solution of the PpIX-encapsulated silica nanoparticles was used as an indirect method to characterize singlet oxygen generation efficiency. 18 In this case, the decrease in the absorbance of the DPBF added to the aqueous solution of the PpIXencapsulated nanoparticles was monitored as a function of time after irradiation with 532-nm laser light.
Cell Culture
HeLa cells ͑human cancer cell lines͒ were cultivated in Dulbecco minimum essential media ͑DMEM͒ with 10% fetal bovine serum ͑FBS͒, 1% penicillin, and 1% amphotericin B. One day before the treatment, cells were seeded in 35-mm cultivation dishes at a confluence of 70 to 80%. During the treatment, a 200-l stock solution of PpIX-encapsulated silica nanoparticles was added to a HeLa cell plate. A 200-l stock solution of Nile red-encapsulated silica nanoparticles was added to another HeLa cell plate for a control experiment. A third HeLa cell plate without any treatment was used for another control experiment. The cell incubation process lasted for 2 hours at 37°C with 5% CO 2 . Then the cells were washed thrice with phosphate buffered saline ͑PBS͒ and directly imaged using a microscopy.
Fluorescence Imaging
Fluorescence imaging of cells was taken from a Nikon E200 microscope ͑as shown in Fig. 2͒ . Green light ͑510 to 560 nm, with a maximal spectrum peak at 535 nm͒ was used to excite the cell sample through the same 40ϫ / 0.65 objective lens that collected the fluorescence signal for imaging. After passing through a long wavelength-pass ͑LP͒ optical filter ͑590-nm LP͒, all the fluorescence signals were received by the CCD, which was installed on the top of the microscope, and then transferred to software in a personal computer. 
In Vitro PDT
To confirm the photon-induced toxicity effect of PpIXencapsulated silica nanoparticles, HeLa cells targeted by them were irritated by a 532-nm light source at the dosage of ϳ2 mW/ cm 2 for 2 minutes ͑as shown in Fig. 2͒ . Cells were observed and imaged under the microscope. Over the next 8 minutes, cell images were successively recorded every 2 minutes for further analysis. In the control experiments, the same experimental procedure was also carried out for HeLa cells targeted by the Nile red-encapsulated nanoparticles and the nontreated HeLa cells. Figure 3 is the TEM image of the PpIX-encapsulated silica nanoparticles. These nanoparticles were all spherical in shape, highly monodispersed, and had an average diameter of 25 nm. The extinction spectra and fluorescence emission spectra of PpIX before ͑in DMSO͒ and after encapsulation ͑in water͒ are shown in Fig. 4 . The extinction spectra of the aqueous solution of PpIX-encapsulated nanoparticles were similar to the extinction spectra of the PpIX in DMSO solution around their spectra peaks ͑about 405 nm; these extinction peaks are mainly due to the absorption͒. However, the PpIXencapsulated silica nanoparticles extincted more light than the PpIX in DMSO. The difference mainly arose from the Rayleigh scattering by the nanoparticles, since the nanoparticles were about 25 nm in diameter ͑comparable to light wave-lengths͒ while PpIX molecules were only about 1 nm in diameter and their scattering effect was almost negligible. According to Mie theory, 19 ͉m 2 −1/ m 2 +2͉ 2 was not negligible, either ͑otherwise, Im͕m 2 −1/ m 2 +2͖ should be very small, and consequently the absorption efficiency Q abs should be negligible, which is not consistent with the experimental result͒. From these analyses, we can conclude that the PpIX-encapsulated nanoparticles ͑average diameter: 25 nm͒ had a non-negligible scattering efficiency. Furthermore, these nanoparticles showed virtually no extinction in the wavelength region of 700 to 800 nm ͑which is considered to be an optical window due to the high penetration depth of light in tissue at these wavelengths͒, but had a strong absorption around 400 nm. This property makes them potentially useful in two-photon excited PDT applications with the light source of a near-infrared laser. [21] [22] [23] The fluorescence emission spectra of the PpIX before and after the encapsulation were almost the same; however, some slight changes of the wavelength and intensity of the fluorescence emission spectra of the PpIX can be observed after the encapsulation. The emission peak of the PpIX after encapsulation was 634 nm, which had red-shifted 2 nm compared with the emission peak of the PpIX before encapsulation; this slight change may be attributed to the surrounding media. Before encapsulation, the PpIX molecules were surrounded by hydrophobic DMSO, while after encapsulation, the PpIX molecules were surrounded by silica nanoparticles dispersed in a hydrophilic aqueous solution.
Results and Discussion
Characterization of PpIX-Encapsulated Silica Nanoparticles
After encapsulation, the PpIX molecules showed a secondary emission peak around 671 nm, which is also a characteristic emission peak of PpIX. 22 Since the silica nanoparticles could protect the PpIX molecules against direct contact with the aqueous solution and make them more stable chemically, the fluorescence intensity of the PpIX molecules in the 580 to 620-nm and 660 to 700-nm regions became more obvious after encapsulation. Regardless, the fluorescence of PpIX can be easily extracted from the excitation light with a long-wavelength-pass optical filter in fluorescence microscopy.
Results of ROS Detection
The released 1 O 2 was detected indirectly using DPBF as a 1 O 2 chemical probe. 18 The DPBF reacted irreversibly with the 1 O 2 generated by the photoexcitation of the PpIXencapsulated nanoparticles, and the reaction was easily monitored by recording the decrease ͑with time͒ in the absorption intensity of the DPBF at 407 nm. The changes in the absorption spectra of DPBF with time after the irradiation in the presence of nanoparticles were obvious, as shown in Figs. 5͑a͒ and 5͑d͒. The slope of curve "a" in Fig. 5͑d͒ is an indication of the efficiency of generating 1 O 2 ͑a steeper slope corresponds to a higher efficiency͒. To show that the absorption decrease of DPBF was really caused by the 1 O 2 , two control experiments were carried out under the same experimental conditions. As shown in Fig. 5͑b͒ and 5͑d͒ , irradiation at 532 nm over 7 minutes caused almost no change in the absorption the PpIX-encapsulated nanoparticles without DPBF probes, which indicated that the absorption property of the PpIX-encapsulated nanoparticles was not affected by the generated 1 O 2 and light irradiation. As shown in Fig. 5͑c͒ and 5͑d͒, irradiation at 532 nm over 7 minutes caused little change in the absorption of DPBF without the PpIXencapsulated nanoparticles, which means the DPBF was rela-tively stable under 532-nm irradiation. These control experiments demonstrate that the decrease in the DPBF absorption at around 407 nm was due only to the simultaneous presence of the PpIX-encapsulated nanoparticles, DPBF, and irradiation, and this 1 O 2 detection method based on the DPBF probes is effective and convincing.
In Vitro Cell Imaging
Fluorescence imaging was used to determine whether the PpIX-encapsulated nanoparticles were taken up by the HeLa cells. Figure 6 contains transmission and fluorescence images ͑under green light excitation͒ showing that the bright red fluorescence ͑which was emitted by the PpIX͒ covered the HeLa cells very well, and the targeting was clear and uniform. No obvious aggregation could be observed ͑otherwise a large and extremely bright spot would appear͒. The PpIX molecules were successfully transferred into the HeLa cells using silica nanoparticles as the carriers. Furthermore, the silica nanoparticles were relatively transparent for both the activation light and fluorescence, which helped to maintain the light intensity. Herein, the targeting at tumor cells was achieved through the "enhanced permeability and retention" effect ͑due to the ultrasmall size and surface charge of the PpIX-encapsulated silica nanoparticles͒. The PpIX-encapsulated silica nanoparticles had net cationic charges on them ͑Zeta-Potential: +8 mV͒, and the HeLa cells had anionic charges on their membranes. The favorable electrostatic interaction facilitated the uptake of the cationic amino-functionalized nanoparticles by the HeLa cells. Such targeting can be applied in, e.g., a situation when a tumor site has been localized before the PDT treatment. For an in vivo experiment and clinical treatment, certain biomolecules like apo-transferrin and antibodies ͑whose receptors are over-expressed in cancer cells͒ can be conjugated with PpIX-encapsulated silica nanoparticles. The biomoleculeconjugated nanoparticles can then accumulate selectively in tumor tissues through receptor-mediated uptake.
Results of In Vitro PDT
The photon-induced toxicity effect of PpIX-encapsulated nanoparticles is shown in Fig. 7 . Here we chose a 532-nm light source with a dosage of ϳ2 mW/ cm 2 to treat the HeLa cell plate. After a 2-minute irradiation, the morphology of the HeLa cells did not change much compared with that of the HeLa cells before irradiation. However, 2 minutes after the 2-minute irradiation, the edges of the HeLa cells already showed some morphologic changes that became more and more obvious as time went by. Eight minutes after the irra-diation, great changes could be observed in the HeLa cells, and the cell structures were destroyed.
To confirm that the changes in the HeLa cells were related to cell necrosis and were due to the ROS generated by the PpIX, and not due to the toxicity from the light irradiation or silica nanoparticles, the same experimental procedure was carried out for the HeLa cells targeted by Nile redencapsulated nanoparticles and the nontreated HeLa cells as control experiments. As shown in Fig. 8 , no obvious change in the morphology of the nontreated HeLa cells could be observed after the light irradiation, indicating the excitation light power was safe for these cells and did not cause direct toxicity. Figure 9 also shows no obvious change in the morphology of the HeLa cells targeted by Nile red-encapsulated nanoparticles ͑the fluorescence imaging is also shown in Fig. 9͒ after the light irradiation, indicating the silica nanoparticles were biocompatible. Here, Nile red is a type of organic fluorescent dye used to track the uptake of silica nanoparticles by fluorescence imaging, not a type of photosensitizer.
By combining the above experimental results, we can conclude that the destruction of the HeLa cells was related to cell necrosis and was induced by the ROSs generated by the PpIX. The whole procedure relied on the fact that oxygen could be well-contacted with encapsulated PpIX, which can be stimulated by light and released. The mesoporosity property of as- Fig. 7 Transmission images of HeLa cells treated with PpIXencapsulated silica nanoparticles: ͑A͒ before irradiation; ͑B͒ after 2-min irradiation; ͑C͒ to ͑E͒ 2, 4, and 8 min after 2-min irradiation ͑scale bar is 50 m͒. 
